Short Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Rises By 2,500.0%

by · The Cerbat Gem

Oxford Biomedica plc (OTCMKTS:OXBDF – Get Free Report) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 2,600 shares, an increase of 2,500.0% from the October 15th total of 100 shares. Based on an average daily volume of 700 shares, the short-interest ratio is presently 3.7 days.

Oxford Biomedica Stock Up 6.1 %

Oxford Biomedica stock traded up $0.31 during mid-day trading on Thursday, reaching $5.41. The company’s stock had a trading volume of 4,750 shares, compared to its average volume of 6,415. Oxford Biomedica has a 12 month low of $2.09 and a 12 month high of $5.68. The business’s 50 day simple moving average is $4.96 and its 200 day simple moving average is $4.46. The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48.

Oxford Biomedica Company Profile

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Recommended Stories